GOSH Study: Tablet Savings for NHS
Analysis based on 7 articles · First reported Apr 09, 2026 · Last updated Apr 10, 2026
The study by Great Ormond Street Hospital suggests significant cost savings for the United Kingdom — National Health Service by transitioning children from liquid to tablet forms of medications like Diazoxide. This could lead to increased demand for tablet forms of certain drugs and potentially impact pharmaceutical companies producing liquid formulations.
Experts from Great Ormond Street Hospital conducted a study revealing that children as young as seven with congenital hyperinsulinism can successfully switch from liquid Diazoxide to more cost-effective and preferred tablet forms. This change could save the United Kingdom — National Health Service approximately £40,000 per patient annually. The study, co-led by Antonia Dastamani and Kate Morgan, also highlighted significant improvements in the quality of life for patients like Jess Manktelow, who found tablets easier to take and manage. Great Ormond Street Hospital plans to further assess the viability of this switch for children as young as four, potentially leading to broader changes in medication administration within the United Kingdom — National Health Service.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard